Literature DB >> 2772976

Serial electrocardiographic recording in aneurysmal subarachnoid hemorrhage.

P J Brouwers1, E F Wijdicks, D Hasan, M Vermeulen, E F Wever, H Frericks, J van Gijn.   

Abstract

We prospectively studied serial electrocardiograms in 61 patients with aneurysmal subarachnoid hemorrhage. Electrocardiographic changes were related to the initial level of consciousness, to subsequent events, and to outcome after 3 months. All 61 patients had at least one abnormal electrocardiogram, but cardiac disease did not contribute directly to morbidity or mortality. Fast rhythm disturbances, ischemic changes, or both on the electrocardiograms were significantly correlated with poor outcome but not with specific outcome events, particularly not with rebleeding or cerebral ischemia. The Glasgow Coma Scale score on admission and the amount of cisternal and (to a lesser extent) intraventricular blood on the initial computed tomogram were also significantly correlated with poor outcome, but these factors only partially confounded the relation between electrocardiographic abnormalities and poor outcome. We conclude that in patients with aneurysmal subarachnoid hemorrhage, electrocardiographic abnormalities do not herald impending cardiac disease but indirectly reflect adverse intracranial factors. Electrocardiographic abnormalities may therefore have some independent value in predicting poor outcome.

Entities:  

Mesh:

Year:  1989        PMID: 2772976     DOI: 10.1161/01.str.20.9.1162

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

Review 1.  Cardiopulmonary complications of brain injury.

Authors:  Alexander Grunsfeld; Jeffery J Fletcher; Barnett R Nathan
Journal:  Curr Neurol Neurosci Rep       Date:  2005-11       Impact factor: 5.081

2.  Haemodynamic, intracranial pressure and electrocardiographic changes following subarachnoid haemorrhage in rats.

Authors:  J Verlooy; J Van Reempts; M Haseldonckx; M Borgers; P Selosse
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Traumatic subdural haematoma with electrocardiographic abnormalities simulating myocardial infarction.

Authors:  A J H H M van Oostrom; H W Mauser; E F D Wever
Journal:  Neth Heart J       Date:  2009-10       Impact factor: 2.380

4.  [Inverted takotsubo cardiomyopathy due to subarachnoid haemorrhage].

Authors:  G Michels; R Pfister
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-21       Impact factor: 0.840

5.  Relationship of Troponin T and Age- and Sex-Adjusted BNP Elevation Following Subarachnoid Hemorrhage with 30-Day Mortality.

Authors:  Katherine M Duello; Jay P Nagel; Colleen S Thomas; Joseph L Blackshear; William D Freeman
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

Review 6.  Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature.

Authors:  Christos Lazaridis; Gustavo Pradilla; Paul A Nyquist; Rafael J Tamargo
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

7.  Case studies in cardiac dysfunction after acute aneurysmal subarachnoid hemorrhage.

Authors:  Jason C Hamilton; Lauren Korn-Naveh; Elizabeth A Crago
Journal:  J Neurosci Nurs       Date:  2008-10       Impact factor: 1.230

8.  Acute myocardial infarction complicating subarachnoid haemorrhage.

Authors:  L B J van der Velden; L C Otterspoor; L J Schultze Kool; G J Biessels; F W A Verheugt
Journal:  Neth Heart J       Date:  2009-08       Impact factor: 2.380

9.  Ventricular arrhythmia risk after subarachnoid hemorrhage.

Authors:  J Michael Frangiskakis; Marilyn Hravnak; Elizabeth A Crago; Masaki Tanabe; Kevin E Kip; John Gorcsan; Michael B Horowitz; Amin B Kassam; Barry London
Journal:  Neurocrit Care       Date:  2009-01-28       Impact factor: 3.210

10.  Inter-observer agreement on the diagnosis of neurocardiogenic injury following aneurysmal subarachnoid hemorrhage.

Authors:  Jeffrey J Fletcher; William Meurer; Malcolm Dunne; Venkatakrishna Rajajee; Teresa L Jacobs; Kyle M Sheehan; Bart Nathan; Allison M Kade
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.